Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014

Background. A group A meningococcal conjugate vaccine (PsA-TT) was developed specifically for the African “meningitis belt” and was prequalified by the World Health Organization (WHO) in June 2010. The vaccine was first used widely in Burkina Faso, Mali, and Niger in December 2010 with great success...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Infect Dis
المؤلفون الرئيسيون: Djingarey, Mamoudou H., Diomandé, Fabien V. K., Barry, Rodrigue, Kandolo, Denis, Shirehwa, Florence, Lingani, Clement, Novak, Ryan T., Tevi-Benissan, Carol, Perea, William, Preziosi, Marie-Pierre, LaForce, F. Marc
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2015
الموضوعات:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639493/
https://ncbi.nlm.nih.gov/pubmed/26553672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ551
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة